157 related articles for article (PubMed ID: 33685728)
1. Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors.
Sasada S; Kimura Y; Masumoto N; Emi A; Kadoya T; Arihiro K; Okada M
Eur J Surg Oncol; 2021 Jul; 47(7):1588-1592. PubMed ID: 33685728
[TBL] [Abstract][Full Text] [Related]
2. Performance of dedicated breast positron emission tomography in the detection of small and low-grade breast cancer.
Sueoka S; Sasada S; Masumoto N; Emi A; Kadoya T; Okada M
Breast Cancer Res Treat; 2021 May; 187(1):125-133. PubMed ID: 33484374
[TBL] [Abstract][Full Text] [Related]
3. The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer.
Sasada S; Shiroma N; Goda N; Kajitani K; Emi A; Masumoto N; Kadoya T; Arihiro K; Okada M
Breast Cancer Res Treat; 2019 Oct; 177(3):651-657. PubMed ID: 31267329
[TBL] [Abstract][Full Text] [Related]
4. Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study.
Sasada S; Masumoto N; Goda N; Kajitani K; Emi A; Kadoya T; Okada M
Eur J Surg Oncol; 2018 Apr; 44(4):444-448. PubMed ID: 29396328
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of dedicated breast positron emission tomography.
Hashimoto R; Akashi-Tanaka S; Watanabe C; Masuda H; Taruno K; Takamaru T; Ide Y; Kuwayama T; Kobayashi Y; Takimoto M; Nakamura S
Breast Cancer; 2022 Nov; 29(6):1013-1021. PubMed ID: 35768684
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral heterogeneity on dedicated breast positron emission tomography predicts malignancy grade of breast cancer.
Masumoto N; Kadoya T; Sasada S; Emi A; Arihiro K; Okada M
Breast Cancer Res Treat; 2018 Sep; 171(2):315-323. PubMed ID: 29779072
[TBL] [Abstract][Full Text] [Related]
7. Distribution pattern of FDG uptake using ring-type dedicated breast PET in comparison to whole-body PET/CT scanning in invasive breast cancer.
Sakaguchi R; Kataoka M; Kanao S; Miyake KK; Nakamoto Y; Sugie T; Toi M; Mikami Y; Togashi K
Ann Nucl Med; 2019 Aug; 33(8):570-578. PubMed ID: 31115856
[TBL] [Abstract][Full Text] [Related]
8. The feasibility of dedicated breast PET for the assessment of residual tumor after neoadjuvant chemotherapy.
Koyasu H; Goshima S; Noda Y; Nishibori H; Takeuchi M; Matsunaga K; Yamada T; Matsuo M
Jpn J Radiol; 2019 Jan; 37(1):81-87. PubMed ID: 30392134
[TBL] [Abstract][Full Text] [Related]
9. Higher breast cancer conspicuity on dbPET compared to WB-PET/CT.
Nishimatsu K; Nakamoto Y; Miyake KK; Ishimori T; Kanao S; Toi M; Togashi K
Eur J Radiol; 2017 May; 90():138-145. PubMed ID: 28583624
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT.
Kalinyak JE; Berg WA; Schilling K; Madsen KS; Narayanan D; Tartar M
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):260-75. PubMed ID: 24085500
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Response to Breast Cancer Neoadjuvant Chemotherapy Using 18F-FDG Positron Emission Mammography Compared With Whole-Body 18F-FDG PET: A Prospective Observational Study.
Noritake M; Narui K; Kaneta T; Sugae S; Sakamaki K; Inoue T; Ishikawa T
Clin Nucl Med; 2017 Mar; 42(3):169-175. PubMed ID: 28072617
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dedicated breast positron emission tomography and whole-body positron emission tomography/computed tomography images: a common phantom study.
Satoh Y; Motosugi U; Imai M; Onishi H
Ann Nucl Med; 2020 Feb; 34(2):119-127. PubMed ID: 31768819
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
Karan B; Pourbagher A; Torun N
J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655
[TBL] [Abstract][Full Text] [Related]
14. Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer: comparison of diagnostic performances of dedicated breast PET, whole-body PET, and dynamic contrast-enhanced MRI.
Tokuda Y; Yanagawa M; Fujita Y; Honma K; Tanei T; Shimoda M; Miyake T; Naoi Y; Kim SJ; Shimazu K; Hamada S; Tomiyama N
Breast Cancer Res Treat; 2021 Jul; 188(1):107-115. PubMed ID: 33730265
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of primary breast cancers using dedicated breast PET and whole-body PET.
Hathi DK; Li W; Seo Y; Flavell RR; Kornak J; Franc BL; Joe BN; Esserman LJ; Hylton NM; Jones EF
Sci Rep; 2020 Dec; 10(1):21930. PubMed ID: 33318514
[TBL] [Abstract][Full Text] [Related]
16. Dedicated breast PET value to evaluate BI-RADS 4 breast lesions.
Graña-López L; Herranz M; Domínguez-Prado I; Argibay S; Villares A; Ruibal A; Vázquez-Caruncho M
Eur J Radiol; 2018 Nov; 108():201-207. PubMed ID: 30396656
[TBL] [Abstract][Full Text] [Related]
17. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
Jung NY; Kim SH; Choi BB; Kim SH; Sung MS
World J Surg Oncol; 2015 Mar; 13():113. PubMed ID: 25889560
[TBL] [Abstract][Full Text] [Related]
18. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
19. Effect of radioactivity outside the field of view on image quality of dedicated breast positron emission tomography: preliminary phantom and clinical studies.
Satoh Y; Imai M; Ikegawa C; Hirata K; Abo N; Kusuzaki M; Oyama-Manabe N; Onishi H
Ann Nucl Med; 2022 Dec; 36(12):1010-1018. PubMed ID: 36207497
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of imaging sensitivity of positron emission mammography and whole-body PET in relation to tumor size.
Yamamoto Y; Ozawa Y; Kubouchi K; Nakamura S; Nakajima Y; Inoue T
Clin Nucl Med; 2015 Jan; 40(1):21-5. PubMed ID: 25423346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
